Andreas Burkhardt
Andreas Burkhardt is the CEO of Pro Generika, the German association representing generic drug manufacturers. He is actively involved in discussions regarding Europe's dependency on Asian pharmaceutical production, particularly in light of recent calls for the EU to enhance its independence in medication supply chains. Burkhardt emphasizes the need for political decisions to determine what pharmaceuticals should be produced in Europe to ensure supply security.
Not in the pool (under ¢1).
Recent news mentions
Andreas Burkhardt was confirmed as a member of the management board.
Rezultati slovenskih blue chipov večinoma pozitivni
Slovenia· 2025-09-23
Andreas Burkhardt warns that Germany's medication supply is in danger due to potential shortages.
News am Morgen - Nachrichten vom 22. September 2025 - Politik
Germany· 2025-09-22
Andreas Burkhardt is the Germany CEO of the Israeli company Teva and chairman of the Pro Generika association.
„Wir können es uns nicht leisten, bei jedem Päckchen noch einen Euro draufzulegen.“ - WirtschaftGermany· 2025-09-21Andreas Burkhardt is the chairman of the German industry association Pro Generika and discusses the political decisions regarding production independence.
Europa muss weniger abhängig von Asien werden
Switzerland· 2025-06-19